The Global Health Observatory

Explore a world of health data

WHO / Yoshi Shimizu

Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents. Five hepatitis viruses - hepatitis A virus (HAV),  hepatitis B virus (HBV), hepatitis C virus ( HCV), hepatitis D virus (HDV) and hepatitis E virus (HEV) can infect humans and cause hepatitis.

 

HBV and HCV infection can become chronic and cause cirrhosis and liver cancer.

 

Data from 187 countries shows that viral hepatitis is a major public health challenge of this decade. An estimated 1.3 million people died from chronic viral hepatitis B and C in 2022 i.e 3500 deaths per day. An estimated 254 million people are living with hepatitis B and 50 million people are living with hepatitis C worldwide, and 6000 people are newly infected with viral hepatitis each day. Many people remain undiagnosed in many countries, and even when hepatitis is diagnosed, the number of people receiving treatment remains incredibly low.

 

High-impact interventions are available, such as an effective cure for hepatitis C and vaccines for hepatitis B, but access to these interventions must be urgently expanded to save lives and prevent a future generation of new infections, cancers and deaths.

 

Key figures

Burden
304 million
people are living with chronic viral hepatitis B and C worldwide in 2022
Incidence
2.2 million
people were newly infected by chronic viral hepatitis B and C in 2022
Deaths
1.3 million
people died of chronic viral hepatitis s B and C in 2022

Hepatitis B highlights

Total number of people infected
254 million
(3.3% of the world's population)
Incidence
1.23 million
(0.81 million–1.53 million) 16 per 100 000 people
Mortality
1.10 million
(0.88 million–1.74 million) 14 per 100 000 people
Percentage of people living with chronic HBV diagnosed
13.4%
Percentage of people living with chronic HBV treated
2.6%

Hepatitis C highlights

Total number of people infected
50 million
(0.7% of the world's population)
Incidence
0.98 million
(0.76 million–1.34 million) 13 per 100 000 people
Mortality
218 000
(197 000–288 000) 3 per 100 000 people
Percentage of people living with chronic HCV diagnosed
36.4%
Percentage of people living with chronic HCV treated
20%

Related indicators

Related content

Publications

Global hepatitis report 2024: action for access in low- and middle-income countries
This is the first consolidated WHO report on viral hepatitis epidemiology, service coverage and product access, with improved data for action. This report...
Consolidated guidelines on person-centred viral hepatitis strategic information: using data to support country scale-up of hepatitis prevention, diagnosis and treatment services

This publication summarizes the approach proposed by WHO to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the...

Guidance for country validation of viral hepatitis elimination and path to elimination

Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully...

Related team

Global Hepatitis Programme
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of viral hepatitis as a public health threat.

Contact us

Please send us your comment or question by e-mail.

If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.